Brief: Cymabay Reports Third Quarter 2020 Financial Results And Provides Corporate Update

CymaBay Therapeutics

05/11/2020 23:16

Nov 5 (Reuters) - Cymabay Therapeutics Inc  CBAY.O :
    * CYMABAY REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS AND
PROVIDES CORPORATE UPDATE
    * Q3 LOSS PER SHARE $0.17
    * Q3 EARNINGS PER SHARE ESTIMATE $-0.17 -- REFINITIV IBES
DATA
    * CYMABAY THERAPEUTICS - HELD $161.3 MILLION IN CASH, CASH
EQUIVALENTS AND SHORT-TERM INVESTMENTS AS OF SEPTEMBER 30, 2020
AND HAD NO OUTSTANDING DEBT
    * BELIEVE THAT CASH AND INVESTMENTS ARE SUFFICIENT TO FUND
CYMABAY'S CURRENT OPERATING PLAN INTO 2022

Source text for Eikon:  ID:nGNX1GGBPZ 
Further company coverage:  CBAY.O 

 ((Reuters.Briefs@thomsonreuters.com;))